The Computer Assessment of Memory and Cognitive Impairment (CAMCI®) is a portable, computerized tool designed to provide a valid assessment of cognitive function in older individuals. CAMCI consists of a set of tasks testing multiple aspects of cognitive function, and a series of self-report questions collecting additional data from the patient. Administered via tablet computer and using touchscreen technology for response input, CAMCI takes approximately 25-30 minutes to complete, and immediately provides a comprehensive
report quantifying and characterizing the patient's cognitive
status. When interpreted by a qualified healthcare
professional, the results of the CAMCI will assist in the
identification of patients with suspected cognitive impairment
for whom further evaluation may be appropriate.
CAMCI is billable under CPT code 96120 (Neuropsychological testing administered by a computer). The reimbursement covers the neuropsychological testing by a computer and the interpretation and reporting time for the physician or clinical psychologist.
Effective 01-01-06: Medicare Part B coverage of neuropsychological tests is authorized under section 1861(s)(2)(C) of the Social Security Act. Payment for neuropsychological tests is authorized under section 1842 (b)(2)(A) of the Social Security Act.
This product is currently in the research, development, and pre-market stage. It is currently only available to researchers with an IRB approved protocol.
CAMCI is intended as a computerized assessment tool to contribute to the clinical assessment of cognitive function in older adults. CAMCI does not offer a medical diagnosis. The results of the CAMCI, when interpreted by a qualified healthcare professional, will assist in the identification of patients with suspected cognitive impairment for whom further evaluation may be appropriate.
Indications for use
CAMCI is indicated for the assessment of cognitive functioning in adults aged 60 or over.
CAMCI should not be used by patients who have uncorrectable visual and/or auditory impairments which would prohibit adequate perception of instructions or stimuli, who have insufficient knowledge of English to understand the instructions or stimuli, or who have a physical disability that would prohibit their ability to respond using the touchscreen/stylus. CAMCI is not approved for in-home use.
These statements have not yet been evaluated by the Food and Drug Administration.
- Accurate and reliable assessment of cognitive function
- More sensitive to mild impairment than the MMSE
- Identifies impaired patients that the MMSE does not
- Computer-administered and self-paced
- Minimal equipment and staff training required
- Standardized administration and scoring
- Automatically and immediately scored
- Clear, comprehensive reporting
- Pre-installed on a medical grade Tablet PC
- Portable, medical grade tablet for use in clinical settings
- HIPAA compliant PHI encryption and storage
- Engaging and enjoyable for patients!
Contact us for more information on the research version of CAMCI.
Q: How does CAMCI work?
A: The CAMCI system consists of the CAMCI software pre-installed on a medical grade tablet PC. No test
administration training required! The CAMCI tasks are
computer-administered, completed by the patient at
their own pace using a digitized pen for input. Data is
automatically logged, scored, and saved in an easy-tointerpret
report format. The comprehensive report provides
individual task scores, an overall score, and classification of
cognitive status in a clear and effective report format. The
CAMCI Manager application permits maintenance of the
patient database and CAMCI system.
Q: What does CAMCI test?
A: CAMCI includes tests of attention, memory (verbal, non-verbal, functional and incidental), executive function, and processing speed. A virtual environment task provides an innovative approach to testing domains, such as
incidental memory, not often assessed by paper-pencil tasks.
Self-report questions capture additional information from the
patient, such as perceived memory loss and alcohol use, that
could influence the interpretation of test results.
Q: Can older patients use a computer?
A: CAMCI is intended to contribute to the clinical assessment of cognitive function in older adults, and has been validated in studies involving adults over the age of 60 with overwhelmingly positive results. Patients report CAMCI is
"fun," "interesting," and "makes you think!"
Q: How are the results reported?
A: Results are available immediately! The comprehensive performance report provides an overall CAMCI score and cognitive classification, adjusted for age and education, in
addition to individual task accuracy and reaction time scores
compared to normative data. Using a two-cutpoint method,
CAMCI reliably classifies normal and impaired patients
while identifying borderline patients who should receive a
"watchful waiting" approach. This group of patients often
reverts to Normal upon follow-up testing. Recommendations
are provided for the physician based on report results.
Q: What is included with my purchase?
A: The CAMCI system includes everything required to run test sessions; CAMCI software applications pre-installed on a medical grade tablet PC, digitized pen, medical grade power
adapter, folding stand, cleaning cloth, and technical support.
Additional accessory equipment for docking, storage, or
audio enhancement is also available to facilitate your use of
CAMCI is currently in the research, development, and pre-market stage. It is currently only available to researchers with an IRB approved protocol.
Please contact us for more information.